Insider Transactions in Q4 2024 at Cumberland Pharmaceuticals Inc (CPIX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 15
2024
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
309
+0.12%
|
$309
$1.3 P/Share
|
|
Oct 15
2024
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
62
+0.0%
|
$62
$1.3 P/Share
|
|
Oct 14
2024
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
62
+0.17%
|
$62
$1.37 P/Share
|
|
Oct 14
2024
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
31
+0.11%
|
$31
$1.37 P/Share
|
|
Oct 14
2024
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
309
+0.12%
|
$309
$1.37 P/Share
|
|
Oct 14
2024
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
62
+0.0%
|
$62
$1.37 P/Share
|
|
Oct 11
2024
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
62
+0.17%
|
$62
$1.39 P/Share
|
|
Oct 11
2024
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
31
+0.11%
|
$31
$1.39 P/Share
|
|
Oct 11
2024
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
309
+0.12%
|
$309
$1.39 P/Share
|
|
Oct 11
2024
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
62
+0.0%
|
$62
$1.39 P/Share
|
|
Oct 10
2024
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
62
+0.17%
|
$62
$1.32 P/Share
|
|
Oct 10
2024
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
31
+0.11%
|
$31
$1.32 P/Share
|
|
Oct 10
2024
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
309
+0.12%
|
$309
$1.32 P/Share
|
|
Oct 10
2024
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
62
+0.0%
|
$62
$1.32 P/Share
|
|
Oct 09
2024
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
62
+0.17%
|
$62
$1.31 P/Share
|
|
Oct 09
2024
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
31
+0.11%
|
$31
$1.31 P/Share
|
|
Oct 09
2024
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
309
+0.12%
|
$309
$1.31 P/Share
|
|
Oct 09
2024
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
62
+0.0%
|
$62
$1.31 P/Share
|
|
Oct 08
2024
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
62
+0.17%
|
$62
$1.3 P/Share
|
|
Oct 08
2024
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
31
+0.11%
|
$31
$1.3 P/Share
|
|
Oct 08
2024
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
309
+0.12%
|
$309
$1.3 P/Share
|
|
Oct 08
2024
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
62
+0.0%
|
$62
$1.3 P/Share
|
|
Oct 07
2024
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
62
+0.17%
|
$62
$1.29 P/Share
|
|
Oct 07
2024
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
31
+0.11%
|
$31
$1.29 P/Share
|
|
Oct 07
2024
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
309
+0.12%
|
$309
$1.29 P/Share
|
|
Oct 07
2024
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
62
+0.0%
|
$62
$1.29 P/Share
|
|
Oct 04
2024
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
62
+0.17%
|
$62
$1.28 P/Share
|
|
Oct 04
2024
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
31
+0.11%
|
$31
$1.28 P/Share
|
|
Oct 04
2024
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
309
+0.12%
|
$309
$1.28 P/Share
|
|
Oct 04
2024
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
62
+0.0%
|
$62
$1.28 P/Share
|
|
Oct 03
2024
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
62
+0.17%
|
$62
$1.28 P/Share
|
|
Oct 03
2024
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
31
+0.11%
|
$31
$1.28 P/Share
|
|
Oct 03
2024
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
309
+0.12%
|
$309
$1.28 P/Share
|
|
Oct 03
2024
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
62
+0.0%
|
$62
$1.28 P/Share
|
|
Oct 02
2024
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
62
+0.17%
|
$62
$1.29 P/Share
|
|
Oct 02
2024
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
31
+0.11%
|
$31
$1.29 P/Share
|
|
Oct 02
2024
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
309
+0.12%
|
$309
$1.29 P/Share
|
|
Oct 02
2024
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
62
+0.0%
|
$62
$1.29 P/Share
|
|
Oct 01
2024
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
62
+0.17%
|
$62
$1.27 P/Share
|
|
Oct 01
2024
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
31
+0.11%
|
$31
$1.27 P/Share
|
|
Oct 01
2024
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
309
+0.12%
|
$309
$1.27 P/Share
|
|
Oct 01
2024
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
62
+0.0%
|
$62
$1.27 P/Share
|